Filter
492
Text search:
Corticosteroids
Featured
Recommendations
86
New Publications
100
Language
Document type
No document type
236
Guidelines
157
Studies & Reports
56
Manuals
13
Fact sheets
12
Strategic & Response Plan
8
Training Material
5
Brochures
3
Resource Platforms
1
Infographics
1
Countries / Regions
India
52
Global
33
South Africa
21
Kenya
17
Africa
16
Ethiopia
14
Tanzania
9
Russia
8
Nepal
7
Latin America and the Carribbean
7
Nigeria
6
Philippines
6
Cambodia
6
Rwanda
6
Bangladesh
6
Malawi
6
Eswatini/ Swaziland
5
Brazil
5
Liberia
4
Ghana
4
Zambia
4
Mozambique
4
Namibia
4
Myanmar / Burma
4
West and Central Africa
4
Western and Central Europe
4
Sierra Leone
3
Senegal
3
Congo, Democratic Republic of
3
Guinea-Bissau
3
USA
3
Uganda
3
Zimbabwe
3
Germany
3
Angola
3
Middle East and North Africa
3
Spain
3
Haiti
2
Syria
2
Indonesia
2
Argentina
2
Ukraine
2
Lesotho
2
East and Southern Africa
2
Burkina Faso
1
Iraq
1
Egypt
1
Thailand
1
Gambia
1
Benin
1
North Macedonia
1
Botswana
1
Yemen
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Bhutan
1
Eastern Europe
1
Albania
1
Iran
1
France
1
Authors & Publishers
Publication Years
Category
Countries
235
Clinical Guidelines
83
Public Health
47
Women & Child Health
20
Key Resources
4
Capacity Building
2
Pharmacy & Technologies
1
Toolboxes
COVID-19
82
NCDs
49
TB
39
NTDs
23
HIV
18
Pharmacy
18
Mental Health
12
AMR
8
Caregiver
8
Ebola & Marburg
5
Rapid Response
5
Refugee
4
Specific Hazards
4
Conflict
3
Zika
3
Health Financing Toolbox
3
Malaria
3
Disability
1
Polio
1
Planetary Health
1
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients
...
Operational Guidelines
The document "Appropriate use and withdrawal of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD)" from the IPCRG provides guidance on when to start, adjust, or discontinue ICS in COPD treatment. It highligh
...
In the European Union, over 20 million people suffer from asthma. During the 1990s there was a rapid decrease in asthma mortality, probably related to the increased use of inhaled corticosteroids (ICS). However, during the last decade, asthma mortal
...
The document discusses the complexities of managing patients with COPD and multiple comorbidities, highlighting the importance of personalized care and the appropriate use of inhaled corticosteroids (ICS). It outlines common comorbidities, such as a
...
The article "Asthma treatment in children: A guide to screening for and management of hypothalamic-pituitary-adrenal axis suppression" discusses the risks associated with the use of corticosteroids in pediatric asthma treatment. It highlights that p
...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blocke
...
As we approach World Asthma Day on the May 2, 2023, we reflect on the theme “ Asthma Care for All”. Prevalence of Asthma is increasing amongst children, adolescents and adults. Under-diagnosis, underutilization of inhaled corticosteroids, inacce
...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE
...
The2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group was coordinated and supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Healt
...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati
...
Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained health professionals, and therapies for disease manageme
...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support
...
The article "Barriers and determinants of asthma control in children and adolescents in Africa: a systematic review" analyzes factors contributing to poor asthma control in African youth. Based on studies conducted between 2014 and 2019 in Nigeria, Uganda, and South Africa, the review identifies key
...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,
...
Several challenges face asthma management in Egypt, including the high percentage of uncontrolled patients, inadequate compliance, and overuse of short-acting beta-agonists (SABAs) leading to increased asthma-related morbidity and mortality. In this regard, the recent Global Initiative for Asthma (G
...
Background
Asthma remains highly prevalent, with more severe symptoms in low-income to middle-income countries (LMICs) compared with high-income countries. Identifying risk factors for severe asthma symptoms can assist with improving outcomes. We aimed to determine the prevalence, severity and ris
...
